Langcongan, Aisa .

HRN: 09-47-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2023
CEFTAZIDIME 1GM (VIAL)
06/08/2023
06/14/2023
IV
1g
Q8
DM Foot
Waiting Final Action 
06/08/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/08/2023
06/14/2023
IV
600mg
Q6
DM Foot
Waiting Final Action 
06/08/2023
MUPIROCIN 2%, 15G (TUBE)
06/08/2023
06/14/2023
TOPICAL
2%
TID
DM Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: